Diabetogenic peptide from human growth hormone: partial purification from peptic digest and long-term action in ob/ob mice.

AUTOR(ES)

Lostroh, A J

RESUMO

Studies in female ob/ob mice demonstrated diabetogenic properties of human growth hormone (somatotropin) and of a fragment generated therefrom by controlled digestion with pepsin; both the fragment and parent growth hormone produce long-term effects on carbohydrate metabolism; in acute glucose tolerance tests, only the fragment is active. Two nonacidic diabetogenic fractions have been separated from inactive fractions by chromatography on Bio-Gel P-6 followed by ion exchange chromatography at pH 4.3 and gel filtration on Bio-Gel P-2 and/or Sephadex G25; these active fractions exhibited multiple NH2-terminal (Lys, Phe, Leu, and Tyr). Fraction CD has these characteristics: (i) It induces glucose intolerance in fasting female ob/ob mice when injected subcutaneously in a divided dose, 15 min before and concurrently with glucose; mice injected with sufficient peptide exhibit elevated fasting glucose levels as long as 7 months after a single glucose tolerance test. (ii) It is a peptide smaller than that reported to stimulate body growth, but larger than somatostatin. This peptide, as reported earlier, does not crossreact with antiserum to human growth hormone in radioimmunoassay.

Documentos Relacionados

• A Hyperglycemic Peptide from Pituitary Growth Hormone: Preparation with Pepsin and Assay in ob/ob Mice*
• Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice.
• Y4 receptor knockout rescues fertility in ob/ob mice
• Long-term production and delivery of human growth hormone in vivo.
• Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice